Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Go William — Janux Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Go William

Go William

Chief Medical Officer at Janux Therapeutics, Inc. · on record since Feb 4, 2026

Insider trading activity of Go William

Transactions on record: 2; since Feb 4, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 4, 2026

Figures computed from official regulatory filings — methodology.

Companies where Go William has traded

Janux Therapeutics, Inc.2 tx · Feb 4, 2026

Track record of Go William

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Go William

Co-insiders of Go William

Avalon BioVentures I, LPJanux Therapeutics, Inc.
Avalon BioVentures SPV I, L.P.Janux Therapeutics, Inc.
Avalon Ventures XI, L.P.Janux Therapeutics, Inc.
Barrett Ronald WJanux Therapeutics, Inc.
Bregua CorpJanux Therapeutics, Inc.
Campbell David AlanJanux Therapeutics, Inc.
CAPPS VICKIE LJanux Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

DiRaimondo ThomasJanux Therapeutics, Inc.

Dobek MariaJanux Therapeutics, Inc.

DOBMEIER ERICJanux Therapeutics, Inc.

Doyle Janeen NoelJanux Therapeutics, Inc.

Godfrey WayneJanux Therapeutics, Inc.

Gujrathi SheilaJanux Therapeutics, Inc.

Heller StefanJanux Therapeutics, Inc.

Hernday NatashaJanux Therapeutics, Inc.

JANEX INTERNATIONAL INCJanux Therapeutics, Inc.

Kolchinsky PeterJanux Therapeutics, Inc.

Kung WinstonJanux Therapeutics, Inc.

Lichter JayJanux Therapeutics, Inc.

McIver ZachariahJanux Therapeutics, Inc.

McNulty Alana B.Janux Therapeutics, Inc.

Meyer Andrew HollmanJanux Therapeutics, Inc.

ORBIMED ADVISORS LLCJanux Therapeutics, Inc.

OrbiMed Capital GP VIII LLCJanux Therapeutics, Inc.

OrbiMed Capital GP VII LLCJanux Therapeutics, Inc.

OrbiMed Genesis GP LLCJanux Therapeutics, Inc.

RA Capital Biotech Fund LPJanux Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCJanux Therapeutics, Inc.

RA Capital Nexus Fund II, L.P.Janux Therapeutics, Inc.

Reardon TigheJanux Therapeutics, Inc.

Robinson ByronJanux Therapeutics, Inc.

Salek-Ardakani ShahramJanux Therapeutics, Inc.

Scott LaurenJanux Therapeutics, Inc.

Shah Rajeev M.Janux Therapeutics, Inc.

Simson JakeJanux Therapeutics, Inc.

Thompson Peter AJanux Therapeutics, Inc.

Winter Charles M.Janux Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Janux Therapeutics, Inc.	Feb 4, 2026	AwardD	154,000	0.00 USD	$0	SEC
Janux Therapeutics, Inc.	Feb 4, 2026	Award	44,000	0.00 USD	$0	SEC